Microcirculation and Oxidative Stress in Critical Ill Patients in Surgical Intensive Care Unit
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
As medicine advances, many lives can be saved in the intensive care unit. However, when multiple organ failure occurs, the mortality rate of patients increases dramatically. Therefore, the major goal in the intensive care unit is to prevent the occurrence of multiple organ failure. The sepsis protocol and early goal directed treatment have great effects to reduce development of multiple organ failure and to decrease the mortality rate. However, sometime the condition of patient deteriorated in spite of both the mean blood pressure and mixed venous oxygen saturation are normal. Some experts recognize that there might be microcirculatory dysfunction of tissue or organ. The dysfunction of microcirculation might due to vasoconstriction or microthrombosis. Vasoconstriction might result from systemic inflammation, reactive oxygen species, or dysfunction of synthesis of NO (nitric oxide). Microthrombosis might result from systemic inflammation, reactive oxygen species, imbalance of coagulatory system, or damage of endothelial cell.
In clinical practice, the oxidative stress is related to circulatory shock, sepsis, acute lung injury, and acute respiratory distress syndrome. This study tries to investigate the relation between oxidative stress and microcirculation. Furthermore, the investigators will try to investigate the correlation between the severity of oxidative stress and microcirculatory dysfunction and the severity of disease and prognosis. The investigators hope this study will help them to figure out the picture of disease progression of patients. It may conduct further study to modulate the oxidative stress, to improve the microcirculatory function, and finally to improve the outcome of patients.
| Condition | Intervention |
|---|---|
|
Sepsis Postoperative Care ARDS Liver Failure Renal Failure Brain Death |
Other: Critical care |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
- Mortality Severity of Organ Failure [ Time Frame: 28 days ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 280 |
| Study Start Date: | September 2007 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
1
Patients with sepsis
|
Other: Critical care
Standard care for each group of patients
|
|
2
Patient admitted for postoperative care
|
Other: Critical care
Standard care for each group of patients
|
|
3
Patients with ARDS
|
Other: Critical care
Standard care for each group of patients
|
|
4
Patients with ARF
|
Other: Critical care
Standard care for each group of patients
|
|
5
Patients who receive liver support treatment
|
Other: Critical care
Standard care for each group of patients
|
|
6
Patients wiht brain death
|
Other: Critical care
Standard care for each group of patients
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Paitents admitted to intensive care unit with the following conditions Sepsis Postoperative care ARDS Renal Failure Liver failure Brain death
Inclusion Criteria:
- > 18 y/o
- Related diagnosis made within 24h
- Group 1 - Sepsis
- Group 2 - Postoperative care
- Group 3 - ARDS
- Group 4 - Renal failure
- Group 5 - Liver failure
- Group 6 - Brain death
Exclusion Criteria:
- Pregnant patients
- Related diagnosis made longer than 24h
- Patients who have received antioxidants within 24h
- Patients who have received hyperbaric oxygen therapy
- Patients who have a hemoglobin value less than 9 g/dl
- Patients who have received NO
Contacts and Locations| Contact: Yu-Chang Yeh, MD | 886-9-68661829 | tonyyeh@ntuh.gov.tw |
| Taiwan | |
| National Taiwan University Hospital | Recruiting |
| Taipei, Taiwan | |
| Contact: Yu-Chang Yeh, MD 886-9-68661829 tonyyeh@ntuh.gov.tw | |
| Principal Investigator: | Yu-Chang Yeh, M.D | National Taiwan University Hospital |
More Information
No publications provided
| Responsible Party: | Yu-Chang Yeh/Doctor, National Taiwan University Hospital |
| ClinicalTrials.gov Identifier: | NCT00808691 History of Changes |
| Other Study ID Numbers: | 200707012 |
| Study First Received: | December 15, 2008 |
| Last Updated: | June 28, 2010 |
| Health Authority: | Taiwan: Department of Health |
Additional relevant MeSH terms:
|
Brain Death Renal Insufficiency Sepsis Liver Failure Brain Diseases Central Nervous System Diseases Nervous System Diseases Coma Unconsciousness Consciousness Disorders Neurobehavioral Manifestations |
Neurologic Manifestations Death Pathologic Processes Kidney Diseases Urologic Diseases Infection Systemic Inflammatory Response Syndrome Inflammation Hepatic Insufficiency Liver Diseases Digestive System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013